Carson J H, Barbarese E, Braun P E, McPherson T A
Proc Natl Acad Sci U S A. 1978 Apr;75(4):1976-8. doi: 10.1073/pnas.75.4.1976.
Components in cerebrospinal fluid that are antigenically related to myelin basic protein have been identified by a technique described recently [Barbarese, E., Braun, P. E. & Carson, J. H. (1977) Proc. Natl. Acad. Sci. USA 74, 3360-3364] involving separating the cerebrospinal fluid proteins by sodium dodecyl sulfate/polyacrylamide gel electrophoresis and measuring the individual components by radioimmunoassay for myelin basic protein. Samples of cerebrospinal fluid from 48 different patients (23 with definite multiple sclerosis, 4 with suspected multiple sclerosis, and 21 with other neurological diseases) were examined by this technique. The results indicate that cerebrospinal fluid can contain at least three separate components that are detected by radioimmunoassay for myelin basic protein. On the basis of their apparent molecular weights, the three components were identified as follows: component I, intact myelin basic protein; component II, proteolytic fragments of myelin basic protein; and component III, a protein of unknown origin with an apparent molecular weight of 50,000. Most samples of cerebrospinal fluid (45 of 48) from patients with multiple sclerosis and from patients with other neurological diseases contained components I and II. Component III was detected in all of the samples from patients with definite multiple sclerosis, in three of four samples from patients with suspected multiple sclerosis, and in none of the samples from patients with other neurological diseases. Some implications of these findings are discussed.
通过一种最近描述的技术[巴尔巴雷塞,E.,布劳恩,P. E.和卡森,J. H.(1977年)《美国国家科学院院刊》74,3360 - 3364],已鉴定出脑脊液中与髓鞘碱性蛋白具有抗原相关性的成分。该技术包括通过十二烷基硫酸钠/聚丙烯酰胺凝胶电泳分离脑脊液蛋白,并通过针对髓鞘碱性蛋白的放射免疫测定法测量各个成分。采用这种技术对48名不同患者(23名确诊为多发性硬化症,4名疑似多发性硬化症,21名患有其他神经系统疾病)的脑脊液样本进行了检测。结果表明,脑脊液中至少可含有三种能通过针对髓鞘碱性蛋白的放射免疫测定法检测到的独立成分。根据它们的表观分子量,这三种成分被鉴定如下:成分I,完整的髓鞘碱性蛋白;成分II,髓鞘碱性蛋白的蛋白水解片段;成分III,一种表观分子量为50,000的来源不明的蛋白质。来自多发性硬化症患者和其他神经系统疾病患者的大多数脑脊液样本(48份中的45份)含有成分I和II。在所有确诊为多发性硬化症患者的样本中、4份疑似多发性硬化症患者样本中的3份以及所有其他神经系统疾病患者的样本中均未检测到成分III。讨论了这些发现的一些意义。